• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ZTS:US

33.0300 USD 0.1700 0.52%

As of 16:15:04 ET on 07/29/2014.

Snapshot for Zoetis Inc (ZTS)

Open: 32.8000 Day's Range: 32.7000 - 33.2200 Volume: 2,994,380
Previous Close: 32.8600 52wk Range: 28.1350 - 33.3400 1-Yr Rtn: +10.75%

Stock Chart for ZTS

No chart data available.
  • ZTS:US 33.0300
  • 1D
  • 1M
  • 1Y
32.8600
Interactive ZTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZTS

Current P/E Ratio (ttm) 24.0589
Estimated P/E(12/2014) 21.5460
Relative P/E vs. SPX 1.3287
Earnings Per Share (USD) (ttm) 1.3729
Est. EPS (USD) (12/2014) 1.5330
Est. PEG Ratio 1.8655
Market Cap (M USD) 16,548.65
Shares Outstanding (M) 501.02
30 Day Average Volume 2,390,483
Price/Book (mrq) 15.3649
Price/Sale (ttm) 3.6158
Dividend Indicated Gross Yield 0.87%
Cash Dividend (USD) 0.0720
Dividend Ex-Date 04/24/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZTS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZTS

Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.

Juan Ramon AlaixChief Executive OfficerGlenn DavidActing CFO/Senior VP:Finance Ops
Kristin C PeckExec VP/Group PresidentRoxanne LaganoExec VP/Chief HR Officer
More Company Profile & Key Executives for ZTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil